Sunshine Biopharma (SBFM) Cash from Operations (2010 - 2026)
Sunshine Biopharma's (SBFM) quarterly Cash from Operations came in at 2072100.0 in Q1 2026, down 22.25% YoY from 2664999.61 in Q1 2025, and down 28.22% on a QoQ basis from 1616006.0 in Q4 2025.
Sunshine Biopharma (SBFM) Cash from Operations (2010 - 2026) Analysis & Trends
Sunshine Biopharma (SBFM) has 17 years of Cash from Operations data on file, last reported at 2072100.0 in Q1 2026.
- Quarterly Cash from Operations fell 22.25% year-over-year to 2072100.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 5708171.0 (up 48.27% YoY) and the FY2025 annual result came in at 5331073.0, up 57.44% from the prior year.
- Cash from Operations eased to 2072100.0 in Q1 2026, from 1616006.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 457289.0 in Q3 2023 to a low of 4577784.0 in Q2 2024.
- A 5-year average of 1997142.41 and a median of 1695002.0 in 2025 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2022 — Cash from Operations slumped 619.81% — and 2025, when it jumped 71.77%.
- Tracing SBFM's Cash from Operations over 5 years: stood at 2246612.0 in 2022, then slipped by 19.72% to 2689676.0 in 2023, then dropped by 26.6% to 3405260.0 in 2024, then jumped by 52.54% to 1616006.0 in 2025, then fell by 28.22% to 2072100.0 in 2026.
- The last three Cash from Operations figures came in at 2072100.0 (Q1 2026), 1616006.0 (Q4 2025), and 727800.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 411.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 655.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 800.69 Mn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 313.60 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 381.80 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 136.40 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 277.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Sunshine Biopharma | 1.52 Mn | -12.23 Mn | 2.43 Mn | -917,977.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -917,977.00 |
| Jun 30, 2026 | -917,977.00 |
| Mar 31, 2026 | -2.07 Mn |
| Mar 31, 2026 | -2.07 Mn |
| Dec 31, 2025 | -1.62 Mn |
| Dec 31, 2025 | -1.62 Mn |
| Sep 30, 2025 | -727,800.00 |
| Sep 30, 2025 | -727,800.00 |
| Jun 30, 2025 | -1.29 Mn |
| Jun 30, 2025 | -1.29 Mn |
| Mar 31, 2025 | -1.70 Mn |
| Mar 31, 2025 | -1.70 Mn |
| Dec 31, 2024 | -3.41 Mn |
| Dec 31, 2024 | -3.41 Mn |
| Sep 30, 2024 | -1.36 Mn |
| Sep 30, 2024 | -1.36 Mn |
| Jun 30, 2024 | -4.58 Mn |
| Jun 30, 2024 | -4.58 Mn |
| Mar 31, 2024 | -3.19 Mn |
| Mar 31, 2024 | -3.19 Mn |